Strongbridge Biopharma plc

Ownership Transactions Reported by 11 Insiders

Industry
Pharmaceutical Preparations
Location
900 Northbrook Drive, Suite 200, Trevose, PA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Strongbridge Biopharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fredric J. Cohen Chief Medical Officer $330K Oct 5, 2021
Garheng Kong Director Oct 5, 2021
Cdk Associates, L.L.C. 10%+ Owner Oct 5, 2021
Richard S. Kollender President and CFO Oct 5, 2021
Stephen J. Long Chief Legal Officer Oct 5, 2021
Marten Steen Director Oct 5, 2021
Scott L. Wilhoit Chief Commercial Officer Oct 5, 2021
David N. Gill Director Oct 5, 2021
John Johnson Chief Executive Officer, Director Oct 5, 2021
Jeffrey W. Sherman Director Oct 5, 2021
Hilde Steineger Director Oct 5, 2021

Recent Insider Transactions by Companies or Individuals for Strongbridge Biopharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.